Document is current
Any future updates will be listed below
-
Authors
Doyle, Brittany R.
Nairon, Emerson B.
Jones, Erica
Salter, Amber
Olson, DaiWai M.
-
Funding
Funding for this research was provided by:
Chiesi USA
- License Information
-
More Information
Article History
Received: 20 August 2024
Accepted: 20 January 2025
First Online: 21 January 2025
Competing interests
: DaiWai Olson is the editor-in-chief of the Journal of Neuroscience Nursing. Amber Salter receives research funding from Multiple Sclerosis Society of Canada, National Multiple Sclerosis Society, CMSC and the Department of Defense Congressionally Directed Medical Research Program and is a member of editorial board for Neurology. She serves as a consultant for Gryphon Bio, LLC, Sora Neuroscience and Abata Therapeutics. She has equity in Owl Therapeutics. She is a member of the Data and Safety Monitoring Board for Premature Infants Receiving Milking or Delayed Cord Clamping (PREMOD2), Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis (CAVS-MS), Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD) and Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH). She holds the Kenney Marie DixonâPickens Distinguished Professorship in Multiple Sclerosis Research. All other authors have no competing interests.
